ImageBiopsy Lab (IB Lab) is a Health-AI startup based in Vienna. We are dedicated to offer solutions for the prediction and assessment of bone diseases of which osteoarthritis (OA) is the most common one worldwide. Standardization and automation in the image grading relieves the physicians of manual work. Changes in cartilage (Joint Space Narrowing as well as Joint Space Area) and bone micro-architecture are automatically assessed, freeing up time resources by automatically generating a patient centric report of the diagnosis.
IB Lab’s mission is to enhance patients diagnostic experience and go beyond the current standard of care. Currently, 100 million people suffer from OA in US and Europe alone. By 2040, this number is predicted to exceed 140 million. Diagnoses are often too late, subjective and might lag details due to time pressure. This demands a solution – now. IB Lab uses state-of-the-art computer-vision and deep learning to efficiently solve these problems.
Publications and Press: